Omnia Health is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Unraveling the complexity: Navigating the U.S. healthcare system sales cycle

Article-Unraveling the complexity: Navigating the U.S. healthcare system sales cycle

Supplied Healthcare sales cycle.png
Collaborative ventures aimed at streamlining procurement processes, optimizing resource utilization, and driving innovation have yielded tangible dividends.

In the realm of healthcare economics, the United States stands as a pivotal case study, juxtaposed between soaring expenditures and fluctuating outcomes. As we delve into the labyrinth of statistics, policies, and partnerships, a nuanced understanding of the American healthcare landscape emerges.

The US allocates a staggering chunk of its GDP to healthcare spending, far outstripping its global counterparts. Roughly 17.7 per cent of the nation’s GDP is funneled into healthcare, as per the latest data. This figure, while emblematic of the country’s commitment to healthcare, places it at the zenith of global healthcare expenditures. Comparatively, countries like Switzerland and Germany trail behind, dedicating around 12 per cent and 11 per cent of their GDP, respectively, to healthcare.

Yet, juxtaposed against this colossal spending, the question arises: Are Americans reaping commensurate benefits in terms of health outcomes? Regrettably, the answer is a resounding NO. Despite its lavish investment, the US lags behind its peers in several key health metrics. Life expectancy, infant mortality rates, and preventable mortality rates all paint a sobering picture of subpar health outcomes.

A deeper dive into the American healthcare infrastructure reveals a labyrinth of hospitals and healthcare systems. The US boasts over 6,200 hospitals, ranging from small community clinics to sprawling medical centers. These institutions wield significant purchasing power, collectively spending billions annually on supplies directly tied to patient care. Major manufacturers and suppliers such as Johnson & Johnson, Medtronic, Medline, Cardinal Health, and GE Healthcare dominate this intricate supply chain, supplying everything from MRI machines to sutures to disposable syringes.

However, amidst this bustling marketplace, a paradigm shift is underway. Innovations geared towards monitoring hospital spending and clinical outcomes are gaining traction. Advanced analytics platforms and AI-powered solutions offer tantalizing prospects for optimizing resource allocation and enhancing patient care. By scrutinizing expenditure patterns and clinical data, healthcare providers can pinpoint inefficiencies and drive tangible improvements in patient outcomes.

But how does the US government ensure accountability and quality amidst this complex web of transactions? Enter core measures — a set of standardized metrics designed to evaluate clinical performance across various domains. These measures, endorsed by organizations like the Centers for Medicare & Medicaid Services (CMS), serve as yardsticks for assessing the quality of care delivered by hospitals. From mortality rates to readmission rates, these metrics offer invaluable insights into the efficacy of healthcare delivery.

Yet, for suppliers and manufacturers navigating the intricate landscape of US hospitals, challenges abound. Stringent regulations, fierce competition, trade wars, and reimbursement uncertainties pose formidable barriers to entry. The selling process itself is often protracted and multifaceted, involving intricate negotiations and rigorous product evaluations. Success hinges not only on the quality and efficacy of the product but also on forging robust partnerships with healthcare providers.

Amidst these challenges, however, glimmers of hope emerge in the form of exemplary partnerships between hospitals and vendors. Collaborative ventures aimed at streamlining procurement processes, optimizing resource utilization, and driving innovation have yielded tangible dividends. From implementing just-in-time inventory systems to co-developing cutting-edge medical technologies, these symbiotic relationships underscore the transformative potential of strategic collaboration.

The evaluation and adoption of medical supplies and services for hospitals involve a diverse array of stakeholders, each playing a crucial role in the decision-making process. Here are the key stakeholders typically involved:

Hospital Administrators and Executives: Hospital administrators and executives hold ultimate responsibility for the procurement decisions within the hospital. They oversee the strategic direction of the institution, including budget allocation and resource management. Their input and approval are essential for the adoption of new medical supplies and services.

Clinical Staff and Physicians: Clinical staff, including physicians, nurses, and other healthcare professionals, play a vital role in evaluating the efficacy and usability of medical supplies and services. Their firsthand experience with patient care informs their feedback on the suitability of different products and their impact on clinical outcomes.

Supply Chain, Materials Management, and Procurement Teams: Supply chain, materials management and procurement teams are responsible for sourcing, purchasing, and managing inventory of medical supplies and services within the hospital. They collaborate closely with clinical staff to assess needs, evaluate vendors, negotiate contracts, and ensure timely delivery of supplies.

Quality Improvement and Patient Safety Teams: Quality improvement and patient safety teams focus on ensuring that medical supplies and services meet established quality standards and contribute to positive patient outcomes. They may conduct evaluations, audits, and assessments to monitor the performance and safety of products and services.

Finance and Budgeting Departments: Finance and budgeting departments play a critical role in evaluating the cost-effectiveness of medical supplies and services. They analyze budgetary constraints, conduct financial assessments, and provide input on the affordability and long-term sustainability of procurement decisions.

Regulatory and Compliance Officers: Regulatory and compliance officers ensure that medical supplies and services comply with applicable laws, regulations, and industry standards. They assess the regulatory landscape, review vendor qualifications, and verify product certifications to mitigate legal and compliance risks.

Vendor Representatives and Suppliers: Vendor representatives and suppliers offer products and services to hospitals and actively engage with stakeholders throughout the evaluation and adoption process. They provide product demonstrations, offer technical support, address concerns, and negotiate contracts to secure sales.

Patient Advocates and Advisory Groups: Patient advocates and advisory groups represent the interests of patients and advocate for products and services that prioritize patient safety, comfort, and satisfaction. They may participate in product evaluations, offer feedback from a patient perspective, and advocate for patient-centered care.

Technology and Innovation Teams: Technology and innovation teams explore emerging trends, research new technologies, and assess innovative solutions that have the potential to improve patient care and operational efficiency within the hospital. They may pilot test new products and services and facilitate knowledge transfer to clinical staff.

External Consultants and Subject Matter Experts: Hospitals may engage external consultants and subject matter experts to provide specialized expertise, conduct assessments, and offer recommendations on the selection and adoption of medical supplies and services. These consultants bring industry insights, best practices, and impartial perspectives to the decision-making process.

By involving these diverse stakeholders and fostering collaboration, hospitals can make informed decisions about the evaluation and adoption of medical supplies and services that best meet the needs of patients, clinicians, and the organization as a whole.

In conclusion, the American healthcare landscape is a tapestry of paradoxes — a juxtaposition of lavish spending and lackluster outcomes, of innovation and inertia, of challenges and opportunities. As we navigate this complex terrain, one thing remains abundantly clear: the imperative of forging synergistic partnerships, driving innovation, and fostering a culture of cost-conscious clinical accountability to usher in a new era of healthcare excellence.

If you would like to learn more, please join me and an expert panel on June 19 at 2pm as we discuss how to navigate the US health system sales cycle.

Kenneth C Wong

Kenneth C. Wong, FACHE, CEO, Consultant, Adjunct Professor, Past President and board member of the American College of Healthcare Executives of South Florida.

Sign up here to register for FIME 2024, the largest medical trade show in the US, and learn more about the latest trends disrupting the industry.

Back to Management

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.